Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) mechanisms to tackle the root causes of obesity. It ...
The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound ...
as the first prescription medication for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. Manufactured by Eli Lilly and Company, Zepbound offers a new approach to ...
However, while continuous positive airway pressure has established itself as the treatment for moderate to severe OSA, people with snoring and mild apnea lack clinically proven options.
Obstructive sleep apnea affects millions of people worldwide, so there is plenty of ongoing research dedicated to the treatment of OSA. However, there is no cure for sleep apnea. So why can't ...
After a shocking diagnosis of sleep apnea, Annie Prescott dove into her treatment. She learned it was important to take the disorder seriously and that she could feel so much better. Does snoring ...